Malady Mongers: How Drug Companies Sell Treatments By Inventing Diseases

1
360

From Huffington Post: The pharmaceutical industry’s image has been significantly damaged in recent years as the public discovered the role its aggressive marketing played in fueling the opioid epidemic. But the American people are still largely in the dark about what may be pharma’s most effective tactic for pushing drugs — marketing diseases.

There’s a substantial body of medical literature dating back to the early ’90s about the practice known as “disease mongering.” Pharmaceutical companies regularly pathologize everyday experiences, convince doctors that they are serious problems, tell a hypochondriacal public it needs help and offers the cure: a new drug. Against the onslaught of billions of dollars in marketing campaigns each year, however, researchers’ warnings about these tactics have gone largely unheeded.

Article →

Support MIA

MIA relies on the support of its readers to exist. Please consider a donation to help us provide news, essays, podcasts and continuing education courses that explore alternatives to the current paradigm of psychiatric care. Your tax-deductible donation will help build a community devoted to creating such change.

$
Select Payment Method
Personal Info

Credit Card Info
This is a secure SSL encrypted payment.

Billing Details

Donation Total: $20

1 COMMENT

  1. Wow! Somebody gets it. The psycho-pharmaceutical industrial complex is in the business of selling “disease” labels. Buy one, and a refillable bottle of prescription drugs comes with it. “Cessation of “treatment”…Whoa! Perish the thought! That’s our livelihood you know.” (My explanation for all the “chronicity” on the planet.)